Multiple cerebral infarctions related to famotidine-induced eosinophilia

J Neurol. 2012 Oct;259(10):2229-31. doi: 10.1007/s00415-012-6534-2. Epub 2012 May 15.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acarbose / administration & dosage
  • Adrenergic alpha-1 Receptor Antagonists / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Ulcer Agents / adverse effects*
  • Antihypertensive Agents / administration & dosage
  • Aspirin / administration & dosage
  • Calcium Channel Blockers / administration & dosage
  • Cerebral Infarction / chemically induced*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diffusion Magnetic Resonance Imaging
  • Drug-Related Side Effects and Adverse Reactions / complications*
  • Drug-Related Side Effects and Adverse Reactions / etiology
  • Eosinophilia / chemically induced*
  • Famotidine / adverse effects*
  • Humans
  • Hypertension / complications
  • Hypertension / drug therapy
  • Hypoglycemic Agents / administration & dosage
  • Labetalol / administration & dosage
  • Male
  • Metformin / administration & dosage
  • Middle Aged
  • Nifedipine / administration & dosage
  • Peptic Ulcer / complications
  • Peptic Ulcer / drug therapy*
  • Prazosin / administration & dosage
  • Prazosin / analogs & derivatives
  • Sulfonylurea Compounds / administration & dosage

Substances

  • Adrenergic alpha-1 Receptor Antagonists
  • Anti-Inflammatory Agents, Non-Steroidal
  • Anti-Ulcer Agents
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Hypoglycemic Agents
  • Sulfonylurea Compounds
  • Famotidine
  • glimepiride
  • Terazosin
  • Metformin
  • Nifedipine
  • Aspirin
  • Labetalol
  • Acarbose
  • Prazosin